Stable CAD (Coronary artery disease)

Latest stable coronary artery disease (stable CAD) content in interventional cardiology - research, practice, and education

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

279 results

Complex PCI: tips and tricks

18 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session presents tips and techniques to approach complex PCI: a stent with reins, a novel ostial PCI technique, the Effect of coronary tortuosity on invasive physiology and much more!

Complex PCI: tips and tricks

Recurrent angina: how to solve

18 May 2022 – From EuroPCR 2022

Watch these videos to discover various tips and techniques to deal with recurrent angina, such as the percutaneous reduction of the coronary sinus, the invasive coronary function testing, the vaso-reactivity testing by intracoronary acetylcholine infusion, and more!

Recurrent angina: how to solve

Stable PCI: be careful with the wire

18 May 2022 – From EuroPCR 2022

Watch this session on stable PCI to discover some challenging cases and learn how to face various complications, such as an unexpected coronary perforation, a fracture of an entrapped guidewire, and more!

Stable PCI: be careful with the wire

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR

New tools and techniques in coronary lesion assessment

17 May 2022 – From EuroPCR 2022

Consult this session to learn about new tools and techniques in coronary lesion assessment, such as: the ability of near infra-red spectroscopy to identify vulnerable patients and plaques, the iFR value impact on left internal mammary artery graft patency, the FFR-guided stent optimisation in focal and diffuse coronary...

New tools and techniques in coronary lesion assessment

PCR's Got Talent - Round 1 - Session 1

17 May 2022 – From EuroPCR 2022

Consult this session to discover a selection of cases presented during the round 1 of PCR's Got Talent at EuroPCR 2022: DAPT modulation after PCI for ACS, plaque burden assessment from OCT with deep learning, prognosis of myocardial infarction in patients with cancer, and much more!

PCR's Got Talent - Round 1 - Session 1

The FAME 3 Trial: Quality of Life After Fractional Flow Reserve-guided Stenting Compared With Coronary Bypass Surgery

03 Apr 2022

Luis Ortega-Paz interviews Frederik Zimmermann, first co-author of the FAME 3 Trial which he presented during the American College of Cardiology’s annual scientific sessions. The trial was published simultaneously in the journal Circulation.

Luis Ortega-Paz

Author

Luis Ortega-Paz
The FAME 3 Trial: Quality of Life After Fractional Flow Reserve-guided Stenting Compared With Coronary Bypass Surgery

PCRonline @ ACC 2022 Scientific Sessions

29 Mar 2022

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.

PCRonline @ ACC.22 Scientific Sessions

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

Pre-treatment with P2Y12 inhibitors in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: a report from the Swedish Coronary Angiography and Angioplasty Registry

11 Mar 2022

The optimal timing of the administration of P2Y12 inhibitors in patients with CCS undergoing ad-hoc PCI is unknown. This study aimed to provide observational data to clarify these quandaries.

Kalpa De Silva

Reviewer

Kalpa De Silva
Trisha Suji

Reviewer

Trisha Suji
Pre-treatment with P2Y12 inhibitors in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: a report from the Swedish Coronary Angiography and Angioplasty Registry